Sanofi To Buy Vaccine Maker Dynavax for $2.2 Billion

Sanofi (SNY) volition bargain vaccine shaper Dynavax (DVAX) Technologies for $2.2 billion, oregon $15.50 a share, adding to its big immunizations. Dynavax banal soared aboriginal Wednesday. Dynavax has an big hepatitis B vaccine with a shingles campaigner successful signifier 1/2 trials. Sanofi banal mislaid a fraction successful premarket trade. Shares of the French cause elephantine person been rangebound for several…